SCHEMBL7863691

SCHEMBL7863691

N[C@@H](C=O)Cc1ccc2ccccc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYSLTR2 Q9NS75 1/20 0.42
CYSLTR1 Q9Y271 1/20 0.42
NCF1 P14598 1/20 0.40
NOS2 P35228 1/20 0.40
BACE1 P56817 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
GAA P10253 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862715 1.00 CYP1A2 (0.46) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL14478292 0.77 CYP1A2 (0.54) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL7247476 0.77 CYP1A2 (0.54) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL14478261 0.77 CYP1A2 (0.54) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL1539349 0.77 CYP1A2 (0.46) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL7863689 0.77 CYP1A2 (0.46) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL15203050 0.76 CYP1A2 (0.47) CYP1A2CYSLTR2CYSLTR1NCF1ALDH1A1
SCHEMBL2183632 0.76 CYP1A2 (0.45) CYP1A2CYSLTR2CYSLTR1NCF1NOS2
SCHEMBL839033 0.75 CYP1A2 (0.53) CYP1A2CYSLTR2CYSLTR1ALDH1A1MAPT
SCHEMBL502040 0.75 CYP1A2 (0.53) CYP1A2CYSLTR2CYSLTR1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0683792-B1 LHRH ANTAGONISTS HAVING MODIFIED AMINOACYL RESIDUES AT POSTIONS 5 AND 6 ABBOTT LAB (US) 2001-09-26 EP disclosed
EP-0673254-A4 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS. ABBOTT LAB (US) 1998-11-18 EP disclosed
EP-0683792-A4 LHRH ANTAGONISTS HAVING MODIFIED AMINOACYL RESIDUES AT POSTIONS 5 AND 6. ABBOTT LAB (US) 1998-11-18 EP disclosed
EP-0683792-A1 LHRH ANTAGONISTS HAVING MODIFIED AMINOACYL RESIDUES AT POSTIONS 5 AND 6 ABBOTT LABORATORIES (US) 1995-11-29 EP disclosed
EP-0673254-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1995-09-27 EP disclosed
WO-1994014841-A1 LHRH ANTAGONISTS HAVING MODIFIED AMINOACYL RESIDUES AT POSTIONS 5 AND 6 ABBOTT LABORATORIES (US) 1994-07-07 WO disclosed
WO-1994013313-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1994-06-23 WO disclosed